Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2)
NCT00000327Phase 2Withdrawn
- Sponsor
- University of Colorado Denver
- Start
- Jun 1997
- Primary completion
- Aug 1997
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of buprenorphine, naloxone in heroin dependence, sponsored by University of Colorado Denver. Planned start Jun 1997; status: withdrawn.
02
Drugs
buprenorphinenaloxone
03
Conditions
heroin dependence
Beyond the preview
Go deeper on NCT00000327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000327.